Together with Akt, AMPK is considered the main signaling molecule controlling cardiac functions [ 46].
Although these studies suggest that control of Atf3 expression is important in homoeostatic control of cardiac function, it is difficult to develop a mechanistic understanding of Atf3 function in these models with long-term manipulation of Atf3 expression.
Of pathophysiological significance are mechanisms which directly control cardiac contractile function including ion- and receptor-mediated intracellular signaling pathways.
These results suggest that partial adenosine A1 agonism may be a new way to modulate the sympathetic control of cardiac function.
Thus, the relatively high incidence of insufficient ultrafiltration and recurrent peritonitis may in part have counteracted the positive effects of pUF on volume control and cardiac function.
On the other hand, cardiac neuronal remodeling affecting sympathetic and parasympathetic control of cardiac function have been studied using staining for acetylcholinesterase [ 48], molecular imaging [ 49] and pan-neuronal markers such as PGP9.5 [ 50].
A secondary aim was to determine whether there is a relationship between these biochemical cardiac markers and glycemic control, fetal cardiac function or structure, placental hemodynamics, or perinatal outcome.
In the young hearts, compared with the control group, cardiac function was aggravated (LVDP, +dp/dt and -dp/dt were decreased but LVDEP was increased) in the I/R group (p < 0.05).
Since CVMs from the two sites appear to target separate subpopulations of principal neurons (Cheng et al., 2004) there is an anatomical basis for differential control of cardiac function by location.
On average, women would have augmented sympathetic inhibition, higher cardiac vagal tone, higher heart rate variability, lower susceptibility to arrhythmias, and decreased myocardial contractility than men [ 2, 3, 20], leading to a preponderance of vagal over sympathetic control of cardiac function [ 2- 5].
